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3.1% and 5.6%, respectively; more patients are required to 
determine statistical significance. 
 
Conclusion: RapidArc gives an improved CI around each 
metastasis as well as a lower whole brain dose at 2, 5, and 
12.5 Gy compared to iPlan. This suggests that the RapidArc 
single isocentre technique offers a potential option for the 
treatment of multiple metastases, but further studies into 
optimal arc arrangement, whole brain doses and dosimetric 
delivery are required. In particular, the work of Evan et al 
(2013) suggests that 4-arc VMAT may further improve dose 
conformity, dose fall-off and whole brain doses relative to 
the 2-arc method discussed here. Ongoing work includes a 
comparison to a 4-arc arrangement together with analysis of 
beam-on and treatment times. In addition, investigation into 
the most suitable plan quality metrics such as those 
suggested by Paddick (2000) will be carried out. 
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Purpose or Objective: For postprostatectomy patients at 
higher risk of nodal involvement the irradiation of pelvic 
lymph nodes may improve the therapeutic ratio. Larger 
volumes irradiated for these patients result in increased 
doses delivered to OAR. IMRT and VMAT techniques allow to 
better protect OAR in comparison to 3D-CRT. The aim of this 
study was to compare IMRT and VMAT techniques in terms of 
sparing of OAR. The main attention was paid to pelvic bones’ 
marrow protection. 
 
Material and Methods: Ten patients were selected 
retrospectively for this planning study. The 3D-CRT, IMRT and 
VMAT plans were created for each of patients. Treatment 
plans were generated for prostate bed (PTV1) and pelvic 
lymph nodes (PTV2). The delivered dose to the sum of PTV1 
and PTV2 was 46Gy in 23 fractions and additionally dose 18 
Gy in 9 fractions was delicered to PTV1 Target coverage (at 
least 98% of the PTV received ≥95% of the prescription dose) 
and OAR sparing were compared across techniques. The 
following OAR were delineated: rectum, bladder, bowel bag 
and pelvic bones. The Wilcoxon test was used to compare the 
dosimetric parameters. Dose-values: bowel bag V30Gy[cc], 
pelvic bones V30Gy[%], V40Gy[%], bladder V40Gy[%], 
V50Gy[%], V60Gy[%], rectum V40Gy[%], V50Gy[%], V60Gy[%] 
were considered. 
 
Results: The dosimetric qualities of 3D-CRT, IMRT and VMAT 
plans were comparable for target coverage (the mean value 
of PTV1 V95%, the mean value of PTV2 V95% all >99%). The 
IMRT and VMAT plans resulted in significant reduction in 
pelvic bones V30Gy[%], V40Gy[%], bladder V40Gy[%], 
V50Gy[%], V60Gy[%], rectum V40Gy[%], V50Gy[%], V60Gy[%] 
and bowel bag V30Gy[cc] in comparison to 3D-CRT plans. A 
comparison between IMRT and VMAT techniques shown better 
sparing bone marrow (pelvic bones V30Gy[%]) and increase of 
following values: bowel bag V30Gy[cc], bladder V60Gy[%], 
rectum V60Gy[%] in VMAT plans. Differences between values 
of V40Gy[%] and V50Gy[%] for bladder and rectum across 
mentioned techniques were statistically not significant. 
 
Conclusion: The lower doses delivered to pelvic bones and 
thus also to red marrow for IMRT and VMAT techniques allow 
to expect the lower hematological toxicity. A comparison 
between IMRT and VMAT techniques shows, that the VMAT 
technique reduces the delivered dose to pelvic bones. 
However IMRT provided better rectum, bladder and bowel 
bag sparing at higher doses. All these results should be taken 
into consideration when IMRT and VMAT techniques being 
used in WPRT of patients after radical prostatectomy.  
 
 
 
EP-1702  
Cardiac dose evaluation in left breast cancer radiotherapy: 
Direct and Helical Tomotherapy 
A. Fozza1, L. Berta
1AUSL Valle d'Aosta, Radiation Oncology, Aosta, Italy 
2, S. Aimonetto2, F. Migliaccio1, A. Peruzzo 
Cornetto2, L. Vigna2, T. Meloni3, F. Munoz1 
2AUSL Valle d'Aosta, Medical Physics, Aosta, Italy 
3AUSL Valle d'Aosta, Radiology Department, Aosta, Italy 
 
Purpose or Objective: The aim of the present study was to 
retrospectively evaluate the delivered doses to the cardiac 
structures for two different tomotherapy techniques in 
adjuvant radiotherapy for early stage left breast cancer 
patients 
 
Material and Methods: Five consecutive conservatively 
operated left breast cancer patients, who underwent 
adjuvant radiotherapy, were retrospectively considered. CT 
simulation was acquired with patients in a supine position, 
using the breast immobilisation device. Image acquisition was 
performed with a 2.5 mm slice thickness in a free breathing 
modality without contrast agent administration. The 
prescription dose was 45 Gy/20 fr and 50 Gy/20 fr, 
respectively to the PTV2 (left whole breast) and PTV1(tumour 
bed), obtained as a 5 mm isotropic expansion of the CTVs, 
with a 5 mm margin from the skin. The following volumes 
were used for plans optimisation: lungs, right breast, spinal 
cord and PRV, heart. For each patient, two independent 
optimisations were carried out using a fixed ganty technique, 
Tomodirect (TD) and helical technique (HT). For TD planning 
two tangential plus other two-four static beams were used. 
For HT planning, the controlateral lung and breast were 
directionally blocked. All plans were optimized in order to 
minimize dose to OAR according to our internal protocol (lung 
V20<10%, V10<20%, V5<42%, controlateral breast: Dmax<5Gy, 
controlateral Lung: V5<5%) and to obtain a coverage of 
D95>95% and Dmax(1cc) <105% for PTVs. In a second time, 
cardiac structures have been identified on the basis of the 
University of Michigan Cardiac Atlas, and DVH parameters 
(D1%, Daverage, V20, V10, V5) for the left and right ventricle 
(LV, RV), left main coronary (LMC) artery, right coronary (RC) 
artery and left anterior descending coronary (LAD) artery 
were retrospectively evaluated for all plans using the plan 
evaluation tool of the RayStation software v 4.7.2 
 
Results: Constraints on target coverage and OAR constraints 
were respected for both techniques in all plans. All results 
are reported in table 1. HT plans achieved a better 
conformation for the high doses for the whole heart (figure 
1). The average maximum doses were 23±7 and 15±2 for TD 
and HT modality respectively. However HT showed a larger 
low-dose bath and the average doses were 20% higher than 
TD. For the LV the D1%, V10 and V5 for HT plans were 8±3, 
0.6±1, 13±15, vs 19±10, 6.0±2.8, 34±12 for TD plans. 
Considering LAD artery the V20 was 0.1±0.1 with HT vs 29±18 
for TD. On the average, the greater differences in DVH 
parameters between HT and TD plans were observed for V5 in 
LV, (-21.7%), V5 in RV (+14.3%) and V20 in LAD artery (-28.7%) 
 
